NEXGEL, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
NEXGEL, INC. (NXGL) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $2.59 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-28.
Discontinued
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2023-03-28
- NEXGEL, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-09-30 was $1.31M.
- NEXGEL, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-03-31 was $1.28M.
- NEXGEL, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2021 was $2.59M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|
| 2021-12-31 | $2.59M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $1.31M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.28M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |